Casting a glance on a potentially new, wide-ranging antibody technology landscape | Immunology and Biotherapies | Scoop.it
From www.roche.com - April 22, 2015 2:43 AM
Roche currently has several different therapeutic antibody technologies in early clinical development which in the future could hopefully be a strong pillar in addressing the complexity of targeting more than 250 cancer diseases.

Via Krishan Maggon